Instrument Inactif

Autres langues Correvio Pharma Corp Toronto S.E.

Actions

CA14159U3010

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Mark Corrigan Departs as CEO from Correvio Pharma Corp	27/05/20
Justin Renz, CFO Departs from Correvio Pharma Corp	27/05/20
Correvio Pharma Corp. Announces Management Changes	27/05/20
Mercury Pharma Group Limited completed the acquisition of Correvio Pharma Corp..	27/05/20
Correvio Pharma : Obtains Final Order for Plan of Arrangement	21/05/20
Correvio Pharma : Announces Results from Annual General and Special Meeting of Securityholders	15/05/20
Correvio Pharma : Leading Independent Proxy Advisory Firm Glass Lewis Recommends That Correvio Shareholders Vote for the Arrangement With ADVANZ PHARMA	06/05/20
Correvio Pharma Corp. Postpones Announcement of Financial Statements for the First Quarter Ended March 31, 2020	04/05/20
Correvio Pharma : Announces Postponement of Its First Quarter 2020 Financial Results Due to Impacts From COVID-19	04/05/20
Correvio Pharma : Leading Independent Proxy Advisory Firm ISS Recommends That Correvio Shareholders Vote for the Arrangement with ADVANZ PHARMA	01/05/20
Correvio Pharma : Obtains Interim Order For Plan Of Arrangement	08/04/20
Correvio Pharma Corp. Reports Earnings Results for the Full Year Ended December 31, 2019	30/03/20
Correvio Pharma : Reports Full Year 2019 Financial Results	30/03/20
Correvio Pharma Corp. Auditor Raises 'Going Concern' Doubt	30/03/20
CORREVIO PHARMA INVESTOR ALERT By the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Correvio Pharma Corp. - CORV	21/03/20
Correvio Pharma : ADVANZ PHARMA to Acquire Correvio	16/03/20
Mercury Pharma Group Limited entered into an arrangement agreement to acquire Correvio Pharma Corp. for $21.3 million.	16/03/20
Correvio Pharma : Receives NASDAQ Notification Regarding Deficiencies In Minimum Bid Price And Market Value Of Listed Securities	28/01/20
Correvio Pharma : Receives Complete Response Letter From U.S. FDA for Brinavess and Provides Update on Recent Events	24/12/19
Correvio Pharma Corp. Receives Complete Response Letter from U.S. FDA for Brinavess and Provides Update on Recent Events	24/12/19

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Correvio Pharma Corp Toronto S.E.

Actions

CA14159U3010

Autres langues

Filtres